Kezar Life Sciences

-$0.04 (-0.50%) As of 2:52 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KZR and other ETFs, options, and stocks.

About KZR

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer in South San Francisco and California. Its product pipeline include KZR-616, KZR-261, and KZR-TBD.

CEO
John Fowler
Employees
47
Headquarters
South San Francisco, California
Founded
2015

KZR Key Statistics

Market Cap
381.21M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
231.11K
High Today
$7.97
Low Today
$7.88
Open Price
$7.97
Volume
5.93K
52 Week High
$9.79
52 Week Low
$4.61

KZR Earnings

-$0.30
-$0.20
-$0.10
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure